Jackson Thornton Wealth Management LLC Increases Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Jackson Thornton Wealth Management LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 28.0% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 507 shares of the healthcare conglomerate’s stock after acquiring an additional 111 shares during the period. Jackson Thornton Wealth Management LLC’s holdings in UnitedHealth Group were worth $256,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Howard Capital Management Group LLC purchased a new position in shares of UnitedHealth Group during the 3rd quarter worth approximately $341,000. Principal Financial Group Inc. grew its stake in shares of UnitedHealth Group by 11.3% in the 3rd quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate’s stock worth $1,039,933,000 after buying an additional 180,479 shares during the last quarter. Kingsview Wealth Management LLC grew its stake in shares of UnitedHealth Group by 4.1% in the 3rd quarter. Kingsview Wealth Management LLC now owns 10,461 shares of the healthcare conglomerate’s stock worth $6,116,000 after buying an additional 416 shares during the last quarter. Algert Global LLC purchased a new stake in shares of UnitedHealth Group in the 3rd quarter worth approximately $1,763,000. Finally, Truepoint Inc. grew its stake in shares of UnitedHealth Group by 45.2% in the 3rd quarter. Truepoint Inc. now owns 1,082 shares of the healthcare conglomerate’s stock worth $633,000 after buying an additional 337 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Trading Up 1.3 %

Shares of UNH stock opened at $517.72 on Monday. UnitedHealth Group Incorporated has a 52-week low of $436.38 and a 52-week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The firm has a market capitalization of $473.57 billion, a PE ratio of 33.40, a PEG ratio of 1.37 and a beta of 0.62. The stock has a fifty day simple moving average of $510.19 and a two-hundred day simple moving average of $546.71.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion during the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same quarter in the prior year, the business posted $5.83 EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were given a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.62%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Activity

In other news, Director Timothy Patrick Flynn acquired 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The stock was purchased at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 0.33% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on UNH. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research note on Tuesday, December 3rd. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Stephens upped their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research report on Thursday, December 5th. Truist Financial lowered their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research report on Friday, January 17th. Twenty research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Buy” and an average price target of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.